Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase N/A

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Inflectra (infliximab-dyyb) / Alvogen, Celltrion, Mundipharma, Egis, Nippon Kayaku, Pfizer

NCT02557295: An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA

Terminated

N/A

248

Celltrion

Rheumatoid Arthritis

03/20

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites